DPP4 inhibitors lessen the degradation of incretins, hence raising glucose-dependent insulin release. In patients with type 2 diabetes, They can be considered weight neutral. New facts propose that in obese women with PCOS, DPP4 inhibitors have effective results on weight loss and decreased blood glucose ranges. In the course of https://doespcosaffectyourlife23344.aboutyoublog.com/37798819/the-definitive-guide-to-can-i-live-a-normal-life-with-pcos